Panacos Pharmaceuticals, Incorporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Panacos Pharmaceuticals, Incorporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Panacos Pharmaceuticals, Incorporation. The Group's principal activity is the discovery, development and commercialization of small molecule oral drugs for the treatment of HIV and other major human viral diseases. PA-457, its lead product candidate, is an oral HIV drug currently in Phase 2 clinical trials. PA-457 is a drug called Maturation Inhibitors discovered by its scientists and their academic collaborators. It has anti-infective drug candidates in pipeline for major markets with significant, unmet medical needs. The Group is a development stage company.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report